Treatment of Post-Punch Biopsy Bleeding in Apixaban-Treated Patients Using Self-Administered BXP154B

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 24, 2024

Primary Completion Date

March 14, 2024

Study Completion Date

March 18, 2024

Conditions

Wound Bleeding

Interventions

DRUG

BXP154B

BXP154B will be self-administered topically following wound induction

DRUG

Placebo

Placebo will be self-administered topically following wound induction

PROCEDURE

Punch Biopsy

Punch biopsy to leg

Trial Locations (1)

Accel Research Sites Network - DeLand, DeLand

All Listed Sponsors

lead

Bio 54, LLC

INDUSTRY

NCT06205615 - Treatment of Post-Punch Biopsy Bleeding in Apixaban-Treated Patients Using Self-Administered BXP154B | Biotech Hunter | Biotech Hunter